Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.4278
-0.0100 (-2.28%)
Aug 14, 2025, 11:46 AM - Market open
Theriva Biologics Employees
Theriva Biologics had 22 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
22
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,343,364
Market Cap
3.88M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22 | 0 | - |
Dec 31, 2023 | 22 | 1 | 4.76% |
Dec 31, 2022 | 21 | 5 | 31.25% |
Dec 31, 2021 | 16 | 6 | 60.00% |
Dec 31, 2020 | 10 | -1 | -9.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TOVX News
- 3 days ago - Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results - GlobeNewsWire
- 3 months ago - Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results - GlobeNewsWire
- 3 months ago - Theriva Biologics Announces Closing of $7.5 Million Public Offering - GlobeNewsWire
- 3 months ago - Theriva Biologics Announces Pricing of $7.5 Million Public Offering - GlobeNewsWire
- 4 months ago - Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients - GlobeNewsWire
- 5 months ago - Theriva™ Biologics to Present at the 2025 NeauxCancer Conference - GlobeNewsWire
- 5 months ago - Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results - GlobeNewsWire
- 5 months ago - Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual - GlobeNewsWire